Neogen | NEOG - Current Liabilities


Neogen reported $147.05M in Current Liabilities for its fiscal quarter ending in September of 2025.





Current Liabilities Change Date
Agilent USD 2.23B 113M Dec/2025
Avanos Medical USD 165.2M 17.3M Dec/2025
Bio-Rad Laboratories USD 517M 5.3M Dec/2025
Cerus USD 88.43M 4.08M Sep/2025
Danaher USD 6.81B 483M Dec/2025
Idexx Laboratories USD 1.15B 103M Dec/2025
Illumina USD 1.59B 377M Dec/2025
Integra LifeSciences USD 455.98M 91.93M Dec/2025
Neogen USD 147.05M 850K Sep/2025
OraSure Technologies USD 39.8M 453K Dec/2025
Pacific Biosciences Of California USD 72.83M 9.62M Dec/2025
Quidel USD 966.1M 198.2M Dec/2025
Rockwell Medical USD 10.95M 259K Jun/2025
STAAR Surgical USD 68.5M 6.87M Dec/2025
Surmodics USD 19.44M 1.1M Jun/2025
Thermo Fisher Scientific USD 15.19B 301M Dec/2025
Utah Medical Products USD 2.6M 413K Dec/2025
Zoetis USD 2.24B 428M Dec/2025